Stock CLAS.H CLARITAS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Claritas Pharmaceuticals, Inc.

Equities

CLAS.H

CA1806342061

End-of-day quote Toronto S.E.
Other stock markets
 18:00:00 2022-07-18 EDT 		5-day change 1st Jan Change
0.025 CAD -16.67% Intraday chart for Claritas Pharmaceuticals, Inc. -.--% -.--%
2021 Claritas Pharmaceuticals : Updates Proposed Financing with Obsidian, Receives Australian Tax Credit, Starts Phase 1 Study of R-107 MT
2021 Claritas Pharmaceuticals, Inc. Announces Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe Covid-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107 CI
9b2eb242.B0vx9sLP4IBjOLa-_GZnjfOCImhl73l6wkcskpROg7g.fyaWmYu_iscWS4bZlRRS15b7WBIfji8yrygfps4I6dR2Ccazrau2wTBvjg~20ec23a36c1b6959a79660759cd820f2
  1. Stock Market
  2. Equities
  3. CLAS.H Stock
  4. Charts Claritas Pharmaceuticals, Inc.
  5. News Chart